Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method for generating a trained convolutional neural network including at least one invariant integration layer for classifying objects of a digital image of the surroundings of a mobile platform including a plurality of training cycles. Each training cycle includes: providing a digital image of the surroundings of a mobile platform including at least one object; providing a reference image associated with the digital image, the at least one object being labeled in the reference image; providing the digital image as an input signal of the convolutional neural network including at least one invariant integration layer; and adapting the convolutional neural network including at least one invariant integration layer in order to minimize a deviation of the classification from the particular associated reference image upon the classification of the at least one object of the digital image.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: The present invention relates to a process for producing a foam ceramic comprising the steps: producing an aqueous suspension of a first mineral raw material; foaming the suspension with air while adding a foaming agent and a binder to form a light foam; mixing the light foam with a powder or slip of a second ceramic raw material to form a heavy foam; pouring the heavy foam into a mold; drying the molded heavy foam in the mold to form a solid foam; and firing the solid foam in the mold to form the foam ceramic.

Abstract: The present invention relates to a process for producing a foam ceramic comprising the steps: producing an aqueous suspension of a first mineral raw material; foaming the suspension with air while adding a foaming agent and a binder to form a light foam; mixing the light foam with a powder or slip of a second ceramic raw material to form a heavy foam; pouring the heavy foam into a mold; drying the molded heavy foam in the mold to form a solid foam; and firing the solid foam in the mold to form the foam ceramic.

Abstract: Disclosed are a computer-implemented method and system for testing and/or training visual, cognitive and/or eye-hand coordination functions or skills of a user, using a computer or data processing device having a touch-sensitive display, wherein at least one line-shaped object (100) is presented on the touch-sensitive display, wherein the user has to retrace the line(s) of the presented object (100) and wherein the user's retraced line(s) (105) is (are) evaluated in order to determine a characteristic or parameter which relates to deviations and/or conformity (120) between the presented at least one line-shaped object (100) and the user's retraced line(s) (105).

Abstract: Disclosed is a graphical user interface method and apparatus for providing an extended virtual zoom functionality for an object being presented on a display (200) of a data processing device or system which comprises at least two discrete zoom layers (205-220) wherein between the at least two zoom layers it is switched based on a certain user control input (202-204).

Abstract: The present invention relates to synthetic oligopeptides that exhibit inhibitory activity towards cancer invasion and metastasis. The peptides of the invention comprise PRKPKWDK (SEQ ID:2) peptide corresponding to amino acids of 85 to 92 of the matrix metalloproteinase (MMP-2), and fragments, analogs and homologs. The invention also relates to the uses of such peptides as inhibitory of human cancer invasion and metastasis and further to their therapeutic use in preventing and treating other pathological conditions related to the degradation of extracellular matrix by MMPs.

Abstract: Administration of composition to a mammal comprising lysine, proline, arginine, an ascorbic compound, and polyphenols in an effective amount promotes hair growth of the mammal. Administration the composition for promotion of hair growth in a mammal further comprises calcium, magnesium, N-acetyl-cysteine, selenium, copper, and manganese. Use of a composition comprising lysine, proline, arginine, an ascorbic compound, and polyphenols in an effective amount may be used for the preparation of a compound for promoting hair growth in a mammal.

Abstract: The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.

Abstract: The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.

Abstract: The present invention generally relates to the use of selected polypeptides from African Swine Fever virus for the prevention and therapy of African Swine Fever infections as well as other infections, including immune deficiencies in mammals and humans.

Abstract: The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.

Abstract: The description discloses a method of producing therapeutic peptides as vaccines in the prevention of human diseases that are caused by one or more proteins. The method comprises identifying the protein responsible for causing the human disease; identifying one or more signal oligopeptide sequences within the structure of the disease causing protein, the one or more signal oligopeptides representing the amino acid sequence of maximum hydrophilicity; and synthesizing one or more vaccine oligopeptides, the vaccine oligopeptides having amino acid sequences corresponding to the amino acid sequences of the signal oligopeptides of maximum hydrophilicity.

Abstract: The present invention provides biochemical compositions effective in inhibiting an atherogenic process, comprising ascorbic acid, lysine, magnesium, cysteine, pyridoxine HCL, riboflavin, folic acid, cyanocobalamin vitamin B12, S-Adenosyl-L-Methionine (SAMe), choline bitartrate, copper glycinate, epigallocatechin gallate, quercetin, asiatic acid, and pycnogenol.

Abstract: A composition comprising of polyphenols, an ascorbic compound, lysine, and proline, have been found to retard viral activity. As such, methods of treating viral infection, and methods of retarding viral activity are provided herein.